Form D — Endlyz Therapeutics, Inc.
0001231919-26-000464 · filed May 7, 2026
Offering
- Industry
- Other
- Exemptions
- 06b
- Total offering
- $19,650,393
- Total sold
- $17,250,395
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Endlyz Therapeutics, Inc.
- CIK
- 1875514
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 28 STATE STREET
BOSTON, MA 02109 - Phone
- 44 (0)7436124195
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Joanna Wolak · Executive OfficerBOSTON, MA Find on LinkedIn ↗
-
Timothy Edwards · DirectorBOSTON, MA Find on LinkedIn ↗
-
Donmienne Leung · DirectorBOSTON, MA Find on LinkedIn ↗
-
Laurence Barker · DirectorBOSTON, MA Find on LinkedIn ↗
-
Justian Craig Fox · DirectorBOSTON, MA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗